NFE2L2 and myeloid sarcoma: As a promising example, the Nrf2 activator dimethyl fumarate (DMF, Tecfidera®) is currently used to treat the relapsing–remitting form of MS, with rapid and sustained clinical and neurological efficacy [26, 33].